Brief: Cyclo Therapeutics Signs Agreement With Worldwide Clinical Trials To Conduct Pivotal Trial In Niemann-Pick Disease Type C

Cyclo Therapeutics

08/11/2019 13:12

Nov 8 (Reuters) - Ctd Holdings Inc  CTDH.PK :
    * CYCLO THERAPEUTICS SIGNS AGREEMENT WITH WORLDWIDE CLINICAL
TRIALS TO CONDUCT PIVOTAL TRIAL IN NIEMANN-PICK DISEASE TYPE C
    * CTD HOLDINGS INC - TRIAL WILL STUDY INTRAVENOUS
ADMINISTRATION
OF COMPANY'S TRAPPSOL CYCLO DRUG AND WILL FOCUS ON SYSTEMIC AND
NEUROLOGIC OUTCOMES
    * CTD HOLDINGS  - PLANS TO SHARE DESIGN OF PIVOTAL TRIAL IN
SCIENTIFIC ADVICE MEETINGS WITH REGULATORS IN US, EUROPE IN Q1 &
Q2 2020, RESPECTIVELY
    * CTD HOLDINGS INC - ENROLLMENT OF TRIAL IS EXPECTED TO
COMMENCE
SHORTLY THEREAFTER

Source text for Eikon:  ID:nBw1bT9GKa 
Further company coverage:  CTDH.PK 

 ((Briefs@thomsonreuters.com;))